Scientists uncover a new approach for treating aggressive cancer by inhibiting chromatin-modulatory enzyme EZH2
Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during cancer development. They then ...
Feb 24, 2022
0
120